Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 7, 2010

New U.K. Center for Regenerative Medicine to Receive Over $13M in Funding

  • A regenerative medicine manufacturing center is to be established at the University of Loughborough with a portion of a £70 million (about $111.49 million) U.K. Government investment. The Engineering and Physical Sciences Research Council (EPSRC) Centre for Innovative Manufacturing in Regenerative Medicine will carry out research and test new ideas in clinical and industrial settings.

    The center aims to create next-generation platforms for manufacturing regenerative medicines and inform business models, policy, and public debate. Investment from the EPSRC will total £5.3 million (roughly $8.44 million) over five years, with 28 industrial and government partners contributing an additional £3 million (approximately $4.78 million).

    The £70 million government funding also includes the established of a Centre for Innovative Manufacturing in Photonics at the University of Southampton and a Centre for Innovative Manufacturing in Liquid Metal Engineering at Brunel University in London.

     



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »